Clinical Trials Browser

Phase EARLY_PHASE1 × Lymphoma, B-Cell × 1 year × Clear all

NCT04161248 2026-02-02

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, B-Cell

NCT06662227 2026-01-20

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07168291 2025-09-17

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

Phase EARLY_PHASE1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT06446128 2025-08-21

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Phase EARLY_PHASE1 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Phase EARLY_PHASE1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06976437 2025-07-10

A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

Phase EARLY_PHASE1 Recruiting

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT07048353 2025-07-02

CAR-T，MTD

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Lymphoma, B-Cell